Role of nuclear factor kappaB in liver health and disease.
about
The Cytokinome Profile in Patients with Hepatocellular Carcinoma and Type 2 DiabetesInhibition of NF-κB transcriptional activation in HepG2 cells by diterpenoids from the soft coral Sinularia maxima.NF-κB inhibition alleviates carbon tetrachloride-induced liver fibrosis via suppression of activated hepatic stellate cells.Hepatoprotective effects of Limonium tetragonum, edible medicinal halophyte growing near seashoresSignal transducer and activator of transcription 3 in liver diseases: a novel therapeutic target.CYP2J2 overexpression attenuates nonalcoholic fatty liver disease induced by high-fat diet in mice.Employment of digital gene expression profiling to identify potential pathogenic and therapeutic targets of fulminant hepatic failure.Apoptosis Induction in Primary Human Colorectal Cancer Cell Lines and Retarded Tumor Growth in SCID Mice by Sulforaphane.Influence of dietary taurine and housing density on oviduct function in laying hens.Lutein decreases oxidative stress and inflammation in liver and eyes of guinea pigs fed a hypercholesterolemic diet.Ginkgo biloba extract mitigates liver fibrosis and apoptosis by regulating p38 MAPK, NF-κB/IκBα, and Bcl-2/Bax signalingN-acetylcysteine administration does not improve patient outcome after liver resection.A RelA(p65) Thr505 phospho-site mutation reveals an important mechanism regulating NF-κB-dependent liver regeneration and cancer.New surprises of suppressor of cytokine signalling in liver fibrosis.OSAS-related inflammatory mechanisms of liver injury in nonalcoholic fatty liver disease.Fucosylated multiwalled carbon nanotubes for Kupffer cells targeting for the treatment of cytokine-induced liver damage.Effects of armepavine against hepatic fibrosis induced by thioacetamide in rats.AGK enhances angiogenesis and inhibits apoptosis via activation of the NF-κB signaling pathway in hepatocellular carcinoma.Role and Regulation of p65/β-Catenin Association During Liver Injury and Regeneration: A "Complex" Relationship.Protective Effect of Meretrix meretrix Oligopeptides on High-Fat-Diet-Induced Non-Alcoholic Fatty Liver Disease in Mice.HIF-1 α as a Key Factor in Bile Duct Ligation-Induced Liver Fibrosis in Rats.
P2860
Q28546913-8E4D001C-951B-4B49-BE3D-0293891FD29AQ33718757-584F7F20-4AB0-4E5F-8B86-226EABED8F45Q33769605-3E12B710-1128-47A6-B328-13DEF8A8DABBQ34304547-86E81F3F-866F-401A-BE4D-2446292FC06DQ34940989-DEE44C09-45C4-49DC-BEA9-8D376E68FFAEQ34980525-704C7EBD-817F-4D9A-8576-3EF520F231A1Q35033350-0001A475-EE32-428A-8E2B-F52DC6940255Q35116419-63A3CE33-497A-488D-A4C6-F03CC9CBDCBFQ35753751-2A426073-92A8-4B9F-8DCF-10AB97F7573FQ35949151-8920A37D-C226-4BEE-9192-4A98AA9069C8Q36352193-4E7D3009-70D1-456D-B6FE-0B391647283CQ36875476-01119D02-C567-4E0B-9C8B-9DCAB80464C6Q36888168-38F92CCC-B059-4D04-89D3-4F5C12F609FAQ38193547-6305C24F-D5A2-4089-AD89-DB5BA58F6443Q38421096-A07D22A0-F072-4247-8EE8-1C01FEC945E1Q39094882-57DDE649-8468-414F-886A-0E947B2F166BQ39515461-8AD36958-205C-483E-8861-2378F0D45A99Q41910456-A24426D7-83F5-432C-A585-119E90439E2FQ47105113-574EB3D5-C761-4A54-8A28-9FBD781A1148Q48184818-3403937B-8CEC-4C8D-96AA-7D12E98DF971Q51720970-04C269AC-0E55-4235-BBFE-A3CEB2B7CC67
P2860
Role of nuclear factor kappaB in liver health and disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 March 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Role of nuclear factor kappaB in liver health and disease.
@en
Role of nuclear factor kappaB in liver health and disease.
@nl
type
label
Role of nuclear factor kappaB in liver health and disease.
@en
Role of nuclear factor kappaB in liver health and disease.
@nl
prefLabel
Role of nuclear factor kappaB in liver health and disease.
@en
Role of nuclear factor kappaB in liver health and disease.
@nl
P2860
P356
P1433
P1476
Role of nuclear factor kappaB in liver health and disease
@en
P2093
Derek A Mann
P2860
P304
P356
10.1042/CS20090549
P407
P577
2010-03-30T00:00:00Z